Alpha-synuclein spreading in Parkinson's disease

被引:130
|
作者
Recasens, Ariadna [1 ]
Dehay, Benjamin [2 ,3 ]
机构
[1] Ctr Networked Biomed Res Neurodegenerat Dis, Neurodegenerat Dis Res Grp, Vall dHebron Res Inst, Barcelona, Spain
[2] Univ Bordeaux, Inst Malad Neurodegenerat, UMR 5293, F-33076 Bordeaux, France
[3] Ctr Natl Rech Sci, Inst Malad Neurodegenerat, UMR 5293, Bordeaux, France
来源
FRONTIERS IN NEUROANATOMY | 2014年 / 8卷
关键词
alpha-synuclein; spreading; aggregation; Parkinson disease; neurodegenerative diseases; NEURONAL CELL-DEATH; COMPLEX-I; TRANSGENIC MICE; NEURODEGENERATIVE-DISEASES; MEMBRANE ASSOCIATION; DOPAMINERGIC-NEURONS; ALA53THR MUTATION; PATHOLOGY SPREAD; BRAIN-REGIONS; TRANSMISSION;
D O I
10.3389/fnana.2014.00159
中图分类号
R602 [外科病理学、解剖学]; R32 [人体形态学];
学科分类号
100101 ;
摘要
Formation and accumulation of misfolded protein aggregates are a central hallmark of several neurodegenerative diseases. In Parkinson's disease (PD), the aggregation-prone protein alpha-synuclein (alpha-syn) is the culprit. In the past few years, another piece of the puzzle has been added with data suggesting that a-syn may self-propagate, thereby contributing to the progression and extension of PD. Of particular importance, it was the seminal observation of Lewy bodies (LB), a histopathological signature of PD, in grafted fetal dopaminergic neurons in the striatum of PD patients. Consequently, these findings were a conceptual breakthrough, generating the "host to graft transmission" hypothesis, also called the "prion-like hypothesis." Several in vitro and in vivo studies suggest that a-syn can undergo a toxic templated conformational change, spread from cell to cell and from region to region, and initiate the formation of "LB like aggregates," contributing to the PD pathogenesis. Here, we will review and discuss the current knowledge for such a putative mechanism on the orlon-like nature of a-syn, and discuss about the proper use of the term orlon-like.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Autoantibodies to alpha-synuclein in inherited Parkinson's disease
    Papachroni, Katerina K.
    Ninkina, Natalia
    Papapanagiotou, Angeliki
    Hadjigeorgiou, Georgios M.
    Xiromerisiou, Georgia
    Papadimitriou, Alexandros
    Kalofoutis, Anastasios
    Buchman, Vladimir L.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 (03) : 749 - 756
  • [22] A Characterization of Misfolded Alpha-Synuclein in Parkinson's Disease
    Shannon, Daniel
    Bugada, John-Paul
    Collins, Ethan
    Fischer, Ellie
    Hellard, Delaney
    Hoffman, Trevor
    Kellogg, Nick
    Peters, Kyle
    Poetker, Garret
    Young, Logan
    Diao, JiaJie
    FASEB JOURNAL, 2020, 34
  • [23] Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson’s Disease
    Dolgacheva L.P.
    Fedotova E.I.
    Abramov A.Y.
    Berezhnov A.V.
    Biochemistry (Moscow), Supplement Series A: Membrane and Cell Biology, 2018, 12 (1) : 10 - 19
  • [24] Alpha-synuclein and presynaptic functionImplications for Parkinson’s disease
    Simon Lykkebo
    Poul Henning Jensen
    NeuroMolecular Medicine, 2002, 2 : 115 - 129
  • [25] Role of alpha-synuclein and tau in Parkinson's disease
    Trojanowski, JQ
    MOVEMENT DISORDERS, 2004, 19 : S2 - S2
  • [26] Targeting Alpha-Synuclein for the Treatment of Parkinson's Disease
    Rohn, Troy T.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2012, 11 (02) : 174 - 179
  • [27] The central role of alpha-synuclein in Parkinson's disease
    Halliday, G.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 54 - 54
  • [28] Alpha-synuclein and the Parkinson's disease drug pipeline
    Espay, Alberto J.
    McFarthing, Kevin
    PARKINSONISM & RELATED DISORDERS, 2023, 111
  • [29] Colonic Expression of Alpha-Synuclein in Parkinson's Disease
    Hefti, Marco
    Goldsmith, Jeffrey
    Pfannl, Rolf
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2015, 74 (06): : 597 - 597
  • [30] Alpha-Synuclein in Peripheral Tissues in Parkinson's Disease
    Ma, Ling-Yan
    Liu, Gen-Liang
    Wang, Dong-Xu
    Zhang, Mei-Mei
    Kou, Wen-Yi
    Feng, Tao
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (02): : 812 - 823